![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/48 | |
A61K 9/14 | |||
A61K 31/4184 | |||
A61K 47/10 |
(11) | Number of the document | 2575784 |
(13) | Kind of document | T |
(96) | European patent application number | 11727396.1 |
Date of filing the European patent application | 2011-06-01 | |
(97) | Date of publication of the European application | 2013-04-10 |
(45) | Date of publication and mention of the grant of the patent | 2018-08-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2011/002764 |
Date | 2011-06-01 |
(87) | Number | WO 2011/151087 |
Date | 2011-12-08 |
(30) | Number | Date | Country code |
11075047 | 2011-03-14 | EP | |
10075231 | 2010-06-02 | EP |
(72) |
COLLEDGE, Jeffrey, NL
OLTHOFF, Margaretha, NL
|
(73) |
Astellas Deutschland GmbH,
Georg-Brauchle-Ring 64-66, 80992 München,
DE
|
(54) | ORAL DOSAGE FORMS OF BENDAMUSTINE |
ORAL DOSAGE FORMS OF BENDAMUSTINE |